European Journal of Haematology

Cover image for Vol. 87 Issue 5

November 2011

Volume 87, Issue 5

Pages 381–472

  1. Review Article

    1. Top of page
    2. Review Article
    3. Original Articles
    4. Case Reports
    5. Letters to the Editor
    6. Clinical Picture
    1. You have free access to this content
      Recent developments in drug resistance mechanism in chronic myeloid leukemia: a review (pages 381–393)

      Shantashri Vaidya, Kanjaksha Ghosh and Babu Rao Vundinti

      Version of Record online: 2 OCT 2011 | DOI: 10.1111/j.1600-0609.2011.01689.x

  2. Original Articles

    1. Top of page
    2. Review Article
    3. Original Articles
    4. Case Reports
    5. Letters to the Editor
    6. Clinical Picture
    1. Soluble c-Met in serum of patients with multiple myeloma: correlation with clinical parameters (pages 394–399)

      Karin F. Wader, Unn-Merete Fagerli, Randi U. Holt, Magne Børset, Anders Sundan and Anders Waage

      Version of Record online: 16 AUG 2011 | DOI: 10.1111/j.1600-0609.2011.01622.x

    2. NPM1 mutation is a stable marker for minimal residual disease monitoring in acute myeloid leukaemia patients with increased sensitivity compared to WT1 expression (pages 400–408)

      Thomas Kristensen, Michael B. Møller, Lone Friis, Olav J. Bergmann and Birgitte Preiss

      Version of Record online: 11 AUG 2011 | DOI: 10.1111/j.1600-0609.2011.01673.x

    3. Prognostic relevance of cytometric quantitative assessment in patients with myelodysplastic syndromes (pages 409–418)

      Patrizia Falco, Alessandro Levis, Alessandra Stacchini, Maria M. Ciriello, Massimo Geuna, Patrizia Notari, Paola Omedè, Marisa Pautasso, Giuseppina Prato, Giuliana Strola, Daniela Gioia, Margherita Bonferroni, Gianni Cametti, Dario Ferrero, Roberto Freilone, Gianluca Gaidano, Carlo Marinone, Filippo Marmont, Berardino Pollio, Flavia Salvi, Giuseppe Saglio, Mauro Girotto and for the Piedmont MDS Registry – Italy

      Version of Record online: 11 AUG 2011 | DOI: 10.1111/j.1600-0609.2011.01676.x

    4. Comparison of the occurrence of mold infection among patients receiving chemotherapy for acute leukemia versus patients undergoing stem cell transplantation (pages 419–425)

      Anke Janssen, Tjomme van der Bruggen, Pieter-Jan A. Haas, Pim A. de Jong and Monique C. Minnema

      Version of Record online: 26 JUL 2011 | DOI: 10.1111/j.1600-0609.2011.01678.x

    5. Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia (pages 426–433)

      Kai Uwe Chow, Soo-Zin Kim, Nils von Neuhoff, Brigitte Schlegelberger, Stephan Stilgenbauer, Lydia Wunderle, Hans-Joerg Cordes and Lothar Bergmann

      Version of Record online: 23 AUG 2011 | DOI: 10.1111/j.1600-0609.2011.01680.x

    6. Bulky disease has an impact on outcomes in primary diffuse large B-cell lymphoma of the breast: a retrospective analysis at a single institution (pages 434–440)

      Suguru Fukuhara, Takashi Watanabe, Wataru Munakata, Masakazu Mori, Dai Maruyama, Sung-Won Kim, Yukio Kobayashi, Hirokazu Taniguchi, Akiko M. Maeshima, Ryuji Tanosaki, Yoshihiro Matsuno and Kensei Tobinai

      Version of Record online: 19 AUG 2011 | DOI: 10.1111/j.1600-0609.2011.01679.x

    7. Pentraxin 3 predicts complicated course of febrile neutropenia in haematological patients, but the decision level depends on the underlying malignancy (pages 441–447)

      Auni Juutilainen, Matti Vänskä, Kari Pulkki, Sari Hämäläinen, Tapio Nousiainen, Esa Jantunen and Irma Koivula

      Version of Record online: 15 AUG 2011 | DOI: 10.1111/j.1600-0609.2011.01666.x

    8. Acquired von Willebrand syndrome and mitral valve prosthesis leakage. A pilot study (pages 448–456)

      Almudena Pérez-Rodríguez, Joana Costa Pinto, Esther Lourés, Ángela Rodríguez-Trillo, José J. Cuenca, Javier Batlle and María F. López-Fernández

      Version of Record online: 26 JUL 2011 | DOI: 10.1111/j.1600-0609.2011.01664.x

    9. The β-globin promoter −71 C>T mutation is a β+ thalassemic allele (pages 457–460)

      Shoaib Al Zadjali, Yasser Wali, Fatma Al Lawatiya, David Gravell, Salam AlKindi, Kareema Al Falahi, Rajagopal Krishnamoorthy and Shahina Daar

      Version of Record online: 15 SEP 2011 | DOI: 10.1111/j.1600-0609.2011.01687.x

  3. Case Reports

    1. Top of page
    2. Review Article
    3. Original Articles
    4. Case Reports
    5. Letters to the Editor
    6. Clinical Picture
    1. A patient with a 20-year lag phase between JAK2-V617F+ myeloproliferation and NPM1-mutated AML arguing against a common origin of disease (pages 461–463)

      Anne Stidsholt Roug, Charlotte Guldborg Nyvold, Caroline Juhl-Christensen, Mariann Christensen, Susanne Schnittger and Peter Hokland

      Version of Record online: 11 AUG 2011 | DOI: 10.1111/j.1600-0609.2011.01669.x

    2. A severe neonatal presentation of factor II deficiency (pages 464–466)

      Eric Pasmant, Bénédicte Dumont, Jean-Jacques Lacapere, Marie-Dominique Dautzenberg and Annie Bezeaud

      Version of Record online: 11 AUG 2011 | DOI: 10.1111/j.1600-0609.2011.01670.x

  4. Letters to the Editor

    1. Top of page
    2. Review Article
    3. Original Articles
    4. Case Reports
    5. Letters to the Editor
    6. Clinical Picture
    1. Hemojuvelin hemochromatosis receiving iron chelation therapy with deferasirox: improvement of liver disease activity, cardiac and hematological function (pages 467–469)

      Takashi Maeda, Tsuyoshi Nakamaki, Bungo Saito, Hidetoshi Nakashima, Hirotsugu Ariizumi, Kouji Yanagisawa, Ai Hattori, Yasuaki Tatsumi, Hisao Hayashi, Kenshi Suzuki and Shigeru Tomoyasu

      Version of Record online: 2 OCT 2011 | DOI: 10.1111/j.1600-0609.2011.01693.x

    2. Reply to the letter to the editor by Guinn et al (page 470)

      Josef Karban, Heidi Mocikova, Robert Pytlik, Pavel Klener and Marek Trneny

      Version of Record online: 2 OCT 2011 | DOI: 10.1111/j.1600-0609.2011.01699.x

  5. Clinical Picture

    1. Top of page
    2. Review Article
    3. Original Articles
    4. Case Reports
    5. Letters to the Editor
    6. Clinical Picture
    1. The 8p11 myeloid and lymphoid neoplasm (pages 471–472)

      Konstantinos Liapis, Dimitrios Kousiafes, Asimina Papanikolaou, Prokopios Pagratis and Garyfallia Kokkini

      Version of Record online: 11 AUG 2011 | DOI: 10.1111/j.1600-0609.2011.01672.x

SEARCH

SEARCH BY CITATION